Literature DB >> 8748827

Effect of ultra-early referral on management outcome in subarachnoid haemorrhage.

T Inagawa1.   

Abstract

A study was conducted to clarify whether ultra-early referral of patients with subarachnoid haemorrhage (SAH) is effective for improving the management outcome. The subjects were 455 patients who were admitted within 6 h after initial SAH. Of these patients, 289 were treated surgically, 159 of them within 24 h. At 6 months, 228 patients (50%) had a favourable outcome including good recovery or moderate disability, 37 (8%) had severe disability, and 190 (42%) had an unfavourable outcome including vegetative state or death. Of 214 patients with an admission grade IV or V, 47 (22%) had a favourable outcome. In 10 patients, emergency procedures such as haematoma removal or ventriculostomy were definitely effective, and in 13, early surgery may have been the reason for the improved outcome. However, in 24 patients, the reasons for a favourable outcome were not related directly to ultra-early referral; in 19 of them, there was spontaneous improvement of clinical grade and/or no SAH on computed tomography. Of 218 patients with admission grade I or II, 30 (14%) had an unfavourable outcome, and in 12 of them, this was ascribed to rebleeding. The rebleeding rate and severity of vasospasm were not significantly reduced by surgery carried out within 24 h after SAH, in comparison with surgery carried out between 24 and 48 h, and there was no significant difference in surgical outcome between them. It is concluded that although ultra-early referral of patients with SAH was expected to improve the outcome in emergency cases, no substantial improvement in overall management outcome seems to have been achieved by this policy.

Entities:  

Mesh:

Year:  1995        PMID: 8748827     DOI: 10.1007/bf01411435

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  56 in total

1.  Aneurysmal subarachnoid hemorrhage in Izumo City and Shimane Prefecture of Japan. Outcome.

Authors:  T Inagawa; M Takahashi; H Aoki; S Ishikawa; H Yoshimoto
Journal:  Stroke       Date:  1988-02       Impact factor: 7.914

2.  Timing of admission and management outcome in patients with subarachnoid hemorrhage.

Authors:  T Inagawa
Journal:  Surg Neurol       Date:  1994-04

3.  Timing of aneurysm surgery.

Authors:  N F Kassell; C G Drake
Journal:  Neurosurgery       Date:  1982-04       Impact factor: 4.654

4.  Subarachnoid hemorrhage of unknown etiology: early prognostic factors for long-term functional capacity.

Authors:  W Oder; H Kollegger; K Zeiler; P Dal-Bianco; P Wessely; L Deecke
Journal:  J Neurosurg       Date:  1991-04       Impact factor: 5.115

5.  Subarachnoid haemorrhage of unknown aetiology.

Authors:  G C Andrioli; G Salar; L Rigobello; S Mingrino
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

6.  Infarction after aneurysm rupture does not depend on distribution or clearance rate of blood.

Authors:  P J Brouwers; E F Wijdicks; J Van Gijn
Journal:  Stroke       Date:  1992-03       Impact factor: 7.914

7.  Ultra-early rebleeding within six hours after aneurysmal rupture.

Authors:  T Inagawa
Journal:  Surg Neurol       Date:  1994-08

8.  Epidemiology of subarachnoid hemorrhage in Finland from 1983 to 1985.

Authors:  C Sarti; J Tuomilehto; V Salomaa; J Sivenius; E Kaarsalo; E V Narva; K Salmi; J Torppa
Journal:  Stroke       Date:  1991-07       Impact factor: 7.914

9.  Computed tomography in the evaluation of intracranial aneurysms and subarachnoid hemorrhage.

Authors:  G Scotti; R Ethier; D Melançon; K Terbrugge; S Tchang
Journal:  Radiology       Date:  1977-04       Impact factor: 11.105

10.  Computerized tomography and prognosis in early aneurysm surgery.

Authors:  L M Auer; G H Schneider; T Auer
Journal:  J Neurosurg       Date:  1986-08       Impact factor: 5.115

View more
  1 in total

1.  Timing of operation for poor-grade aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial.

Authors:  Qiao Zhang; Lu Ma; Yi Liu; Min He; Hong Sun; Xiang Wang; Yuan Fang; Xu-hui Hui; Chao You
Journal:  BMC Neurol       Date:  2013-08-19       Impact factor: 2.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.